Dow Pharmaceutical Sciences Inc.
1330 Redwood Way
Petaluma, CA 94954-1169
Tel: 707.793.2600
Fax: 707.793.0145
vwaters@dowpharmsci.com

Publications

Information on Topical Drug Delivery Systems And Processes

To open an article or poster about topical drug delivery systems from Dow Pharmaceutical Sciences, Inc., click the associated link.

Type	Title	Links
Poster	Characterization of Potential Percutaneous Absorption and Penetration Differences of Human Dermatomed Skin and Dermis-Only with Various Receptor Phase Flow Rates, In Vitro, using (3H)-Clotrimazole and (3H)-Hydrocortisone as Model Compounds
Article	Rationale & Design of Studies to Screen & Identify Promising Topical Formulations
Poster	Characterization of Potential Percutaneous Absorption Differences of Skin, Vaginal, Buccal, Corneal and Scleral Tissues, In Vitro, using (3H)-Clotrimazole and (3H)-Hydrocortisone as Model Compounds
Article	Topical drug development: Formulation through preclinic
Poster	Patch Testing for Optimizing Mildness of an Emollient Spray
Article	Formulation Development of Modern Dermatologicals
Article	It's all on the Skin
Article	Dow Opens New Skin Biology Lab
Article	Dow Adding 10,000sf in Petaluma
Article	Skin Penetration and Drug Release to Optimize Dermatological Formulations
Article	Skin Penetration Enhancers Cited in the Technical Literature [4mb]
Poster	Skin Barrier Function: Implications in the Development of Topical Products
Poster	An In Vitro Model using Newborn Bovine Eyes to Assess Cornea & Sclera Permeation

 

Note: Posters are in most cases reproduced from a full poster board size. To view the entire poster image, please scroll the page both horizontal as well as vertical.